๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Evommune, Inc. (EVMN)
NYSE: EVMN ยท Real-Time Price ยท USD
7.04
-0.20 (-2.76%)
At close: Nov 20, 2026, 4:00 PM EST
7.03
-0.01 (-0.14%)
After-hours: Nov 20, 2026, 7:30 PM EST

Evommune Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Revenue
-1375
Revenue Growth
-85.71%40.00%-
Gross Profit
-1375
Operating Income
-121.89-81.07-70.01-37.85
Net Income
-113.07-68.87-68.31-34.05
Earnings Per Share
-3.59-11.22-45.29-27.17
EPS Growth
----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Cash & Investments
168.64149.272.0479.08
Total Debt
8.192.061.021.26
Net Cash (Debt)
160.45147.1471.0277.83
Net Cash Growth
113.08%107.19%-8.75%-
Net Cash Per Share
5.0923.9847.0962.10

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-90.4-76.44-58.2-29.97
Capital Expenditures
-0.6-0.24-0.09-0.12
Free Cash Flow
-91-76.68-58.28-30.09
Free Cash Flow Growth
----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Gross Margin
-100.00%100.00%100.00%
Operating Margin
--623.62%-1000.19%-757.00%
Pretax Margin
--529.77%-954.40%-681.06%
Profit Margin
--529.77%-975.83%-681.06%
FCF Margin
--589.82%-832.61%-601.76%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingNov '26 Dec '25 Dec '24 Dec '23
PS Ratio
-41.52--